United States · FDA National Drug Code directory
Docetaxel
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67457-781_fea50522-6e4c-4ae0-81ac-53863693cc06
- Product NDC
- 67457-781
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- Docetaxel
- Labeler
- Mylan Institutional LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190618
- Source listing expiry
- 20261231
Source-listed ingredients
- DOCETAXEL — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (67457-781-08) / 8 mL in 1 VIAL, MULTI-DOSE · 67457-781-08
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →